MMIR.F Stock Overview

A biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Europe, and internationally. More details

MMIR.F fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Earnings have declined by 23.8% per year over past 5 years

Makes less than USD$1m in revenue (CA$277K)

Negative shareholders equity

Has less than 1 year of cash runway

+ 2 more risks

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

MedMira Inc. Competitors

Daxor

NasdaqCM:DXR

US$36.0m

Apyx Medical

NasdaqGS:APYX

US$53.3m

Modular Medical

NasdaqCM:MODD

US$40.1m

Global Innovative Platforms

OTCPK:GIPL

US$39.8m

Price History & Performance

Summary of share price highs, lows and changes for MedMira
Historical stock prices
Current Share Price	CA$0.021
52 Week High	CA$0.09
52 Week Low	CA$0.013
Beta	0.83
1 Month Change	0%
3 Month Change	n/a
1 Year Change	-65.50%
3 Year Change	-72.03%
5 Year Change	-92.86%
Change since IPO	-49.51%

Recent updates

Shareholder Returns

	MMIR.F	US Medical Equipment	US Market
7D	0%	1.2%	5.1%
1Y	-65.5%	6.8%	10.6%

Return vs Industry: MMIR.F underperformed the US Medical Equipment industry which returned 6.8% over the past year.

Return vs Market: MMIR.F underperformed the US Market which returned 10.6% over the past year.

Price Volatility

Is MMIR.F's price volatile compared to industry and market?
MMIR.F volatility
MMIR.F Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	9.6%
Market Average Movement	8.1%
10% most volatile stocks in US Market	16.9%
10% least volatile stocks in US Market	4.2%

Stable Share Price: MMIR.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine MMIR.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1993	n/a	Hermes Chan	medmira.com

MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product for preliminary screening of HIV and hepatitis. It also provides the Miriad RVF toolkit, which facilitates the development and commercialization of rapid diagnostics; and REVEALCOVID-19 and Reveal G4 HIV tests.

MedMira Inc. Fundamentals Summary

How do MedMira's earnings and revenue compare to its market cap?
MMIR.F fundamental statistics
Market cap	US$40.14m
Earnings (TTM)	-US$3.19m
Revenue (TTM)	US$197.86k

202.9x

P/S Ratio

-12.6x

P/E Ratio

Is MMIR.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MMIR.F income statement (TTM)
Revenue	CA$276.73k
Cost of Revenue	CA$967.56k
Gross Profit	-CA$690.83k
Other Expenses	CA$3.76m
Earnings	-CA$4.46m

Last Reported Earnings

Jan 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	-0.0063
Gross Margin	-249.64%
Net Profit Margin	-1,610.08%
Debt/Equity Ratio	-63.9%

How did MMIR.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/15 21:57
End of Day Share Price	2025/04/09 00:00
Earnings	2025/01/31
Annual Earnings	2024/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

MedMira Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.